Increasingly potent immunosuppressive agents have dramatically reduced the incidence of
rejection of transplanted organs while increasing susceptibility to opportunistic infections …

Infections remain a common complication of solid-organ transplantation. Most infections in
the first month after transplant are typically health care–associated infections, whereas late …

Lifelong immunosuppressive therapy is essential to prevent allograft rejection in transplant
recipients. Long-term, nonspecific immunosuppression can, however, result in life …

Viruses are among the most common causes of opportunistic infection after transplantation.
The risk for viral infection is a function of the specific virus encountered, the intensity of …

Viral infections remain a significant cause of morbidity and mortality following renal
transplantation. Although cytomegalovirus is the most common opportunistic pathogen seen …

It has been suggested that BK‐polyomavirus is linked to oncogenesis via high expression
levels of large T‐antigen in some urothelial neoplasms arising following kidney …

The human polyomavirus type 1, also called BK virus (BKV), causes polyomavirus‐
associated nephropathy (PVAN) in 1–10% of renal transplant recipients, with graft loss in …

Mesenchymal stromal cells have emerged as potential candidates for cell-based therapies
to modulate the immune response in organ transplantation and repair tissues after acute or …

ABSTRACT COVID-19 is impacting provision of renal transplantation in the UK with a
reduction in clinical activity. Publicly available Renal Registry and NHS Blood and …

Solid-organ transplant recipients are at increased risk of developing cancer compared with
the general population. Tumours can arise de novo, as a recurrence of a preexisting …